Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedQuest Products was a medical technology company focused on the development of advanced mechanical circulatory support systems for patients with end-stage congestive heart failure. The company's primary innovation was the HeartQuest Ventricular Assist Device (VAD), a continuous-flow centrifugal blood pump designed to provide long-term support with improved hemocompatibility and reliability. MedQuest was acquired by World Heart Corporation in 2005 for approximately $25 million to integrate its centrifugal pump technology into WorldHeart's next-generation product pipeline. The technology eventually became part of the broader mechanical circulatory support market through subsequent acquisitions by HeartWare and Medtronic. MedQuest's work was instrumental in the transition from bulky pulsatile pumps to the smaller, more durable rotary pumps used in modern cardiac care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedQuest Products.